Other relevant news · Page 5 · Mind Medicine Australia
Mind Medicine Australia logo Menu

Other relevant news

The long history of psychedelics in religion, from ergot-spiked wine to magic mushrooms

ABC News, August 21, 2022

In the last century, psychedelics have gone from being at the cutting edge of medical science, to a symbol of the 1960s counterculture, and back again.

The Need For 100,000 Psychedelic Facilitators Is Real

LA Weekly, August 3, 2022

The experts are pretty sure it’s going to take 100,000 psychedelic facilitators for the new industry to provide treatment to the masses.

Canadian patients fighting for psilocybin access sue federal government

National Post, August 2, 2022

‘This is the landmark case that is going to legalize psychedelics in Canada’

Restrictions on Psilocybin ‘Magic Mushrooms’ Are Easing as Research Ramps Up

Scientific American, August 1, 2022

Here’s how the psychedelic substance’s legal status has been shifting.

Biden administration plans for legal psychedelic therapies within two years

The Intercept, July 27, 2022

A letter from the Health and Human Services Department discloses the anticipated FDA approval of MDMA and psilocybin treatments.

Major health insurer opens door to psychedelic drugs

The Australian, July 26, 2022

Health insurer says psychedelics’ medicinal potential is ‘extraordinary’ amid growing evidence MDMA and psilocybin can be used to treat some mental illnesses.

Microdosing: Scientists tackle psychedelic trend becoming ‘creative enhancer of choice’

The Age, July 23, 2022

Microdosing is a different way of consuming psychedelic medicines, which involves regularly taking small amounts of a psychedelic.

Biotech Check Up: US FDA approves first clinical trial of naturally derived psychedelic drugs

The Australian, July 21, 2022

In a groundbreaking development, the US FDA has just approved a clinical trial studying the effects of naturally derived psychedelic medicines.

Brains, genes and chemical imbalances – how explanations of mental illness affect stigma

The Conversation, July 20, 2022

For three decades, people have been deluged with information suggesting that depression is caused by a “chemical imbalance” in the brain – namely an imbalance of a brain chemical called serotonin. However, our latest research review shows that the evidence does not support it.

Psychedelics for mental health treatment

ABC Nightlife, July 11, 2022

Writer Michael Pollan discusses how psychedelics are being used now and into the future, to successfully treat people with a range of disorders, addictions and mental illnesses.

Can microdosing psychedelics improve your mental health? Here’s what the science says

ABC News, July 3, 2022

Early results from trials on the therapeutic potential of large doses (macrodosing) of psychedelics have been promising.

Psychedelics Give a Glimpse of Enlightenment

Psychology Today, July 3, 2022

Our brains may be filters that are inhibiting us from experiencing reality.

Mark Turner MLA speaks at the Legislative Assembly of the Northern Territory

Mark Turner MLA: Member for Blain, June 28, 2022

Mark Turner MLA advocates for access to psychedelic-assisted psychotherapies at the Legislative Assembly of the Northern Territory.

ACT government agrees to decriminalise small amounts of illicit drugs, such as ice, heroin and cocaine

ABC News, June 9, 2022

The ACT is set to become the first Australian jurisdiction to decriminalise small amounts of commonly used illicit drugs, such as ice, heroin, cocaine and speed.

‘As legal as garlic’: High times in Thailand as marijuana is decriminalised

The Sydney Morning Herald, June 8, 2022

Thailand will on Thursday become the first country in Asia to effectively legalise marijuana in a landmark move its government hopes will supercharge its wellness and tourism industries and generate as much as 10 billion baht ($400 million) per year.

How psychedelic drugs might treat depression

BBC, June 7, 2022

Hallucinogenic mushrooms have shown promise for their medical benefits, but we are only now beginning to understand how they might help to treat depression.

New Study To Evaluate Psilocybin’s Therapeutic Potential On Autistic Adults

Neuroscience News, June 4, 2022

A new study will explore how psilocybin affects different networks and serotonin function in the brains of autistic adults.

Psychedelic retreats target stressed-out corporate executives

Australian Financial Review, June 2, 2022

New businesses are focusing on jurisdictions where drugs such as psilocybin and ketamine are legal, betting they’ll be able to expand when more places decriminalise popular substances.

‘We spark curiosity’: how the psychedelics industry is taking on Davos

The Guardian, June 1, 2022

The Psychedelic House of Davos, a satellite event happening in conjunction with the World Economic Forum, was a ‘genius strategy’ to build credibility, say experts.

A Balm for Psyches Scarred by War

The New York Times, May 29, 2022

MDMA-assisted treatment for post-traumatic stress disorder “represents real hope for long-term healing,” health experts say.

Subscribe to our newsletter

Stay in touch with Mind Medicine Australia: